Haploinsufficiency of a Spliceosomal GTPase Encoded by EFTUD2 Causes Mandibulofacial Dysostosis with Microcephaly


Autoria(s): Lines, Matthew A.; Huang, Lijia; Schwartzentruber, Jeremy; Douglas, Stuart L.; Lynch, Danielle C.; Beaulieu, Chandree; Guion-Almeida, Maria Leine; Zechi-Ceide, Roseli Maria; Gener, Blanca; Gillessen-Kaesbach, Gabriele; Nava, Caroline; Baujat, Genevieve; Horn, Denise; Kini, Usha; Caliebe, Almuth; Alanay, Yasemin; Utine, Gulen Eda; Lev, Dorit; Kohlhase, Jurgen; Grix, Arthur W.; Lohmann, Dietmar R.; Hehr, Ute; Boehm, Detlef; Majewski, Jacek; Bulman, Dennis E.; Wieczorek, Dagmar; Boycott, Kym M.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

30/10/2013

30/10/2013

02/08/2013

Resumo

Mandibulofacial dysostosis with microcephaly (MFDM) is a rare sporadic syndrome comprising craniofacial malformations, microcephaly, developmental delay, and a recognizable dysmorphic appearance. Major sequelae, including choanal atresia, sensorineural hearing loss, and cleft palate, each occur in a significant proportion of affected individuals. We present detailed clinical findings in 12 unrelated individuals with MFDM; these 12 individuals compose the largest reported cohort to date. To define the etiology of MFDM, we employed whole-exome sequencing of four unrelated affected individuals and identified heterozygous mutations or deletions of EFTUD2 in all four. Validation studies of eight additional individuals with MFDM demonstrated causative EFTUD2 mutations in all affected individuals tested. A range of EPTUD2-mutation types, including null alleles and frameshifts, is seen in MFDM, consistent with haploinsufficiency; segregation is de novo in all cases assessed to date. U5-116kD, the protein encoded by EFTUD2, is a highly conserved spliceosomal GTPase with a central regulatory role in catalytic splicing and post-splicing-complex disassembly. MFDM is the fast multiple-malformation syndrome attributed to a defect of the major spliceosome. Our findings significantly extend the range of reported spliceosomal phenotypes in humans and pave the way for further investigation in related conditions such as Treacher Collins syndrome.

government of Canada through Genome Canada

government of Canada through Genome Canada

Canadian Institutes of Health Research (CIHR)

Canadian Institutes of Health Research (CIHR)

Ontario Genomics Institute

Ontario Genomics Institute [OGI-049]

Genome Quebec

Genome Quebec

Genome British Columbia

Genome British Columbia

Physicians Services Incorporated Foundation

Physicians' Services Incorporated Foundation

German Ministry of Research and Education [BMBF 01GM0802]

German Ministry of Education and Research

CIHR Institute of Genetics

CIHR Institute of Genetics

Identificador

AMERICAN JOURNAL OF HUMAN GENETICS, CAMBRIDGE, v. 90, n. 2, supl. 1, Part 3, pp. 369-377, FEB 10, 2012

0002-9297

http://www.producao.usp.br/handle/BDPI/36849

10.1016/j.ajhg.2011.12.023

http://dx.doi.org/10.1016/j.ajhg.2011.12.023

Idioma(s)

eng

Publicador

CELL PRESS

CAMBRIDGE

Relação

AMERICAN JOURNAL OF HUMAN GENETICS

Direitos

restrictedAccess

Copyright CELL PRESS

Palavras-Chave #DOMINANT RETINITIS-PIGMENTOSA #TREACHER-COLLINS-SYNDROME #RIBOSOMAL TRANSLOCASE #CLEFT-PALATE #RNA #MUTATIONS #PROTEIN #HOMOLOG #SNU114P #GENE #GENETICS & HEREDITY
Tipo

article

original article

publishedVersion